Universal Health Services, Inc.

Universal Health Services, Inc. (UHS) Market Cap

Universal Health Services, Inc. has a market capitalization of $11.60B.

Financials based on reported quarter end 2025-12-31

Price: $182.41

β–² 3.68 (2.06%)

Market Cap: 11.60B

NYSE Β· time unavailable

CEO: Marc D. Miller

Sector: Healthcare

Industry: Medical - Care Facilities

IPO Date: 1981-07-09

Website: https://uhs.com

Universal Health Services, Inc. (UHS) - Company Information

Market Cap: 11.60B Β· Sector: Healthcare

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Analyst Sentiment

63%
Buy

Based on 19 ratings

Analyst 1Y Forecast: $246.19

Average target (based on 4 sources)

Consensus Price Target

Low

$231

Median

$244

High

$274

Average

$249

Potential Upside: 36.5%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ Universal Health Services, Inc. (UHS) β€” Investment Overview

🧩 Business Model Overview

Universal Health Services, Inc. (UHS) is a large, diversified healthcare services provider with a dual focus on acute care and behavioral health services. UHS owns and operates a network of hospitals, behavioral health centers, and ambulatory care centers across several regions in the United States, as well as some international locations. The company’s core offerings span inpatient and outpatient acute care (including surgical procedures, emergency services, and specialty treatments) as well as mental health and substance abuse treatment programs. UHS serves a broad customer base that includes individual patients, managed care organizations, government programs, and commercial insurers, with referrals coming from physicians, local agencies, and healthcare systems.

πŸ’° Revenue Model & Ecosystem

UHS generates revenue primarily through patient care servicesβ€”both acute medical and behavioral health offerings. These services are reimbursed by a range of payers, including private insurance companies, government programs (such as Medicare and Medicaid), and self-paying patients. The company’s ecosystem encompasses facility-based care, outpatient services, and support arrangements with insurance networks and health systems. Ancillary service lines, such as diagnostic imaging and therapeutic programs, further support the patient journey and create multiple touchpoints within the healthcare value chain. UHS’s ability to integrate acute and behavioral services enables the company to engage diverse customer segments, from enterprise-level health plan contracts to direct-to-patient scenarios.

🧠 Competitive Advantages

  • Brand strength: UHS is recognized as a prominent operator in both the acute and behavioral health sectors, benefiting from decades of experience and established regional reputations.
  • Switching costs: Patients, insurance partners, and referring physicians often develop long-term relationships with UHS facilities, especially for chronic care needs, resulting in high switching costs.
  • Ecosystem stickiness: The integration of acute and behavioral health services creates natural cross-referral pathways and enhances customer retention across its network.
  • Scale + supply chain leverage: The company’s national footprint provides pricing leverage with suppliers, economies of scale in administration, and the ability to invest in growth or innovation ahead of smaller independent providers.

πŸš€ Growth Drivers Ahead

UHS is well-positioned to benefit from several structural trends, including rising demand for behavioral healthcare, demographic tailwinds due to an aging population, and the ongoing shift from inpatient to outpatient care delivery models. The company pursues growth through new facility development, expansions in underserved regions, and select acquisitions that expand its behavioral health portfolio or acute care presence. Additionally, technology-enabled care models, such as telemedicine and remote behavioral health services, provide avenues for increased patient engagement and operational efficiency. Partnerships with payers and employers further open opportunities to manage larger patient populations under value-based care arrangements.

⚠ Risk Factors to Monitor

Key risks for UHS include intensifying competition from both national healthcare systems and specialized operators in core markets. Regulatory changes impacting reimbursementβ€”such as shifts in Medicare or Medicaid policyβ€”can introduce margin volatility. Labor market pressures, including shortages of clinical staff, may lead to cost escalation or operational disruption. The rapidly evolving healthcare landscape also presents the risk of new entrants, technological disruption, or changes in patient referral patterns. Maintaining high quality and compliance standards is critical in the regulated healthcare sector, and any lapses could affect reputation and future growth.

πŸ“Š Valuation Perspective

Universal Health Services is typically compared to a peer group of diversified healthcare service providers and standalone hospital operators. The market’s valuation tends to reflect the company’s balance of growth trajectory, operational stability, and exposure to both acute and behavioral health markets. Investors may assign a premium or discount depending on perceived regulatory risks, visibility of growth drivers, and UHS’s ability to maintain margin resilience relative to hospital peers and pure-play behavioral health players.

πŸ” Investment Takeaway

The investment case for Universal Health Services, Inc. centers on its leadership positions in both acute and behavioral healthcare, diversified revenue streams, and structural demand for its services. Bullish scenarios include ongoing expansion in behavioral health, successful adaptation to evolving care models, and consistent execution on quality and cost controls. Bearish perspectives caution on competitive intensity, regulatory risk, and the operational complexity of managing a large, geographically dispersed portfolio. Prospective investors should weigh UHS’s scale and operational track record against sector-specific uncertainties and the company's ability to sustain long-term growth and profitability.


⚠ AI-generated research summary β€” not financial advice. Validate using official filings & independent analysis.

UHS delivered strong Q4 and FY25 results with solid pricing, tight cost control, and improving behavioral volumes, while returning significant capital through buybacks. 2026 guidance implies continued growth supported by new capacity, outpatient expansion, and AI-driven efficiencies, but tempered by known headwinds from ACA exchange declines and California behavioral staffing regulations, plus early-year weather impacts. Management’s tone is constructive on core trends and operational execution, with a balanced acknowledgment of external pressures.

Growth

  • Q4 revenue +9% y/y; adjusted EBITDA net of NCI +10%; adjusted EPS +20%
  • FY25 revenue +10%; adjusted EBITDA net of NCI +15%; adjusted EPS +31%
  • Acute Care same-facility: net revenue +6.9% reported (+5.2% ex-insurance); revenue/adjusted admission +5.4%; adjusted admissions flat (ex-Las Vegas +1%)
  • Behavioral Health same-facility: net revenue +7.2%; revenue/adjusted patient day +5.6%; adjusted patient days +1.5%
  • Q4 Same-facility Acute Care EBITDA +10.4%; margin +50 bps to 14.8% (FY margin +150 bps to 15.8%)
  • Behavioral Health EBITDA +6.9% in Q4; +7.8% FY25

Business Development

  • Acute: 3 inpatient expansions (178 beds) slated for 2026 in FL, CA, NV
  • New 156-bed de novo acute hospital in Palm Beach Gardens, FL opening Q2 2026
  • Behavioral: 2 de novo projects totaling 264 beds in 2026, including JV with Jefferson Health (PA)
  • Outpatient behavioral: 119 locations; 10 new freestanding centers opened in 2025 under the 1,000 branches Wellness brand; at least 10 more planned for 2026
  • Behavioral M&A in 2025 (primarily U.K.) to contribute modestly in 2026

Financials

  • Q4 GAAP EPS $7.06; adjusted EPS $5.88
  • Cash from operations $1.9B in 2025 (vs. $2.1B in 2024), impacted by +$50M receivables at recent de novos and -$145M timing of Medicaid supplemental payments
  • 2025 capex $1.0B (~35% to FL de novo and major FL/CA expansions)
  • Acute Care cost control: SWB +4.4% y/y (ex-insurance); supplies +1.8%; contract labor 2.4% of revenue (-20 bps y/y)
  • Behavioral headcount +3.1%; U.S. labor expense/adjusted day +7.3%

Capital & Funding

  • Repurchased 4.65M shares for $899M in 2025; remaining authorization $1.425B
  • Revolver capacity: ~$900M available on $1.3B facility at 12/31/25
  • 2026 capex guidance: $950M–$1.1B (completion of several large inpatient projects)
  • 2026 Medicaid supplemental net benefit assumed at $1.36B (+$23M y/y), including newly approved Nevada program

Operations & Strategy

  • Acute Care expense management: reduced contract labor, improved supply chain, 2% reduction in same-facility length of stay
  • Behavioral staffing investments to relieve capacity constraints and support 2026 volume growth
  • AI deployment: agentic AI for post-discharge follow-up (readmission reduction); AI in revenue cycle (documentation, coding, claims appeals); behavioral referral/intake digitization; new behavioral patient safety tech planned; broader acute AI rollouts in 2026
  • Guided to 2%–3% same-facility volume growth in both segments for 2026; Q1 likely below range due to winter storms (Behavioral, D.C. acute)

Market & Outlook

  • 2026 guidance: revenue $18.4B–$18.8B (+6%–8%); adjusted EBITDA net of NCI $2.64B–$2.79B (+2%–8%); adjusted EPS $22.64–$24.52 (+4%–13%)
  • Pricing assumptions: Acute +3%–4%; Behavioral +2%–3% (moderating after strong recent years)
  • Exchange headwind: -$75M pretax expected; exchange volumes -25%–30% with only 10%–20% shifting to other coverage; majority to self-pay/uninsured; concentrated in Acute (2025: 6% of adjusted admissions, <5% of segment revenue)
  • California inpatient psych staffing regulations effective 6/1/26: -$35M pretax in 2026; ongoing ~-$30M annually thereafter; includes recruiting/training and near-term census disruption
  • Cedar Hill improvement +$50M favorability assumed in 2026; incremental gains offset by Palm Beach Gardens start-up costs
  • Additional +$50M pretax tailwind: absence of a 2025 legal item, Nevada health plan operational improvement, modest U.K. Behavioral M&A contribution
  • Nevada acute market expected to improve in 2026 after 2025 softness tied to lower tourist/respiratory volumes; employment trends stable; stronger convention outlook

Risks Or Headwinds

  • ACA exchange enrollment/premium payment uncertainty driving volume declines and potential bad debt/self-pay mix shift
  • California behavioral staffing mandate increasing labor costs and causing short-term census impacts
  • Weather-related disruptions (winter storms) pressuring Q1 volumes
  • Behavioral pricing moderation vs. recent years
  • Market-specific softness (Las Vegas) and mixed surgical growth vs. medical
  • Timing/variability of Medicaid supplemental payments

Sentiment: MIXED

Note: This summary was synthesized by AI from the UHS Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"Universal Health Services reported revenue of $4.49 billion for the quarter ending December 31, 2025, with a net income of $445.94 million, resulting in an EPS of $7.14. Free cash flow was strong at $293 million, supported by $574 million in operating cash flows against $281 million in capital expenditures. Year-over-year revenue growth is solid, affirming the company's operational strengths, though EPS growth appears modest. Profitability remains robust, reflected by a net margin of nearly 10%. Cash flow generation is stable with strategic stock repurchases totaling $352 million, though accompanied by minimal dividends, indicating a balanced approach to capital allocation. UHS's balance sheet shows a reasonable debt position with net debt at approximately $5 billion against total equity of $7.4 billion. Valuation is in line with analyst expectations, with a median price target around $242, reflecting current market sentiment. Overall, UHS presents a stable financial profile with shareholder-focused capital management, supported by ongoing revenue and income growth."

Revenue Growth

Good

Revenue growth is solid and consistent, driven by steady operational performance.

Profitability

Good

The company maintains healthy operating margins with stable EPS, indicating efficient operations.

Cash Flow Quality

Positive

Strong free cash flow and strategic use of cash for buybacks, though dividends are modest.

Leverage & Balance Sheet

Positive

Modest leverage with net debt at $5 billion; overall financial position is stable.

Shareholder Returns

Good

Consistent value returns via stock repurchases and dividends, focusing on long-term shareholder value.

Analyst Sentiment & Valuation

Good

Valuation metrics are aligned with analyst consensus, indicating fair market assessment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
πŸ“

SEC Filings (UHS)

Β© 2026 Stock Market Info β€” Universal Health Services, Inc. (UHS) Financial Profile